News Release Detail
Mylan to Report Second Quarter 2017 Financial Results on Aug. 9, 2017
The briefing can be accessed live by calling 800.514.4861 or 678.809.2405 for international callers (ID#: 53957196) or at the following address on the company's website: investor.mylan.com. A replay of the webcast will also be available on the website.
Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which approximately 50% of people being treated for HIV/AIDS in the developing world depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time. Learn more at Mylan.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/mylan-to-report-second-quarter-2017-financial-results-on-aug-9-2017-300490436.html
SOURCE
News Provided by Acquire Media